Back
DexCom Vs. Bristol-Myers Squibb Industry Stock Comparison
Sell
46
DXCM
DexCom
Last Price:
70.04
Seasonality Move:
-1.82%
Buy
63
BMY
Bristol-Myers Squibb
Last Price:
50.00
Seasonality Move:
4.77%
Sell
46
DexCom (DXCM)
is a Sell
Is DexCom a Buy, Sell or Hold?
- The current DexCom [DXCM] share price is $69.51. The Score for DXCM is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- DXCM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Bristol-Myers Squibb (BMY)
is a Buy
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $49.13. The Score for BMY is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- BMY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $49.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
DXCM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.48 | Sell |
| Relative Strength Index (14 RSI): | 39.8 | Sell |
| Chaikin Money Flow: | 1455465 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (68.91 - 73.45) | Sell |
| Bollinger Bands (100): | (78.44 - 127.14) | Sell |
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.54 | Buy |
| Relative Strength Index (14 RSI): | 55.01 | Buy |
| Chaikin Money Flow: | 8910088 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.92 - 49.68) | Buy |
| Bollinger Bands (100): | (41.35 - 48.01) | Buy |
DXCM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.07 | Buy |
| 20-day SMA: | 71.25 | Sell |
| 50-day SMA: | 83.24 | Sell |
| 200-day SMA: | 114.45 | Sell |
| 8-day EMA: | 69.37 | Buy |
| 20-day EMA: | 71.52 | Sell |
| 50-day EMA: | 82.03 | Sell |
| 200-day EMA: | 104.9 | Sell |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.03 | Buy |
| 20-day SMA: | 48.98 | Buy |
| 50-day SMA: | 46.58 | Buy |
| 200-day SMA: | 47.72 | Buy |
| 8-day EMA: | 48.93 | Buy |
| 20-day EMA: | 48.7 | Buy |
| 50-day EMA: | 47.26 | Buy |
| 200-day EMA: | 48.77 | Buy |
DexCom Earnings Growth & DXCM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.11 per share, an increase this year of $0.25 per share, and an increase next year of $0.31 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.24 per share, a decrease this year of $6.64 per share, and an increase next year of $6.24 per share.
DexCom Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bristol-Myers Squibb Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||